コンテンツメニュー

Matsuyama Hideyasu

Affiliate Master Yamaguchi University

Can docetaxel therapy improve overall survival from primary therapy compared with androgen-deprivation therapy alone in Japanese patients with castration-resistant prostate cancer? A multi-institutional cooperative study

International journal of clinical oncology Volume 18 Issue 1 Page 62-67
published_at 2013-02
Title
Can docetaxel therapy improve overall survival from primary therapy compared with androgen-deprivation therapy alone in Japanese patients with castration-resistant prostate cancer? A multi-institutional cooperative study
Creators Shimabukuro Tomoyuki
Creators Sakano Shigeru
Creators Matsuda Kenji
Creators Kamiryo Yoriaki
Creators Yamamoto Norio
Creators Kaneda Yoshitaka
Creators Nasu Takahito
Creators Baba Yoshikazu
Creators Suga Akinobu
Creators Yamamoto Mitsutaka
Creators Aoki Akihiko
Creators Takai Kimio
Creators Yoshihiro Satoru
Creators Konishi Motohiko
Creators Imoto Katsuhiko
Creators Matsuyama Hideyasu
Creator Keywords
Castration-resistant prostate cancer (CRPC) Docetaxel (DOC) Androgen-deprivation therapy (ADT) Overall survival (OS) Toxicity
Languages eng
Resource Type journal article
Publishers Churchill Livingstone Springer
Date Issued 2013-02
File Version Not Applicable (or Unknown)
Access Rights metadata only access
Relations
[ISSN]1341-9625
[ISSN]1437-7772
[NCID]AA11086579
[NCID]AA11625629
[PMID]info:pmid/22068464
info:doi/10.1007/s10147-011-0344-x
[isVersionOf] [URI]http://link.springer.com/journal/10147
Schools 大学院医学系研究科(医学)